Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MAGHEAD: Magnesium Sulfate vs Paracetamol for Acute Headache
NCT07779486Recruiting
- Sponsor
- Université de Monastir
- Start
- Jun 2026
- Primary completion
- Dec 2029
- Countries
- 1
01
Overview
Randomised, double-blind trial of magnesium sulfate in Headache (3 arms), sponsored by Université de Monastir. Primary endpoints: Change in Pain Intensity at 60 months and Proportion of Responders at 60 months. Started Jun 2026; status: recruiting.
02
Drugs
magnesium sulfate
03
Conditions
Headache
Beyond the preview
Go deeper on NCT07779486.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07779486.